Genzyme pursues innovation in discovery and development and the strategic acquisition of new resources. Our ability to execute creates the opportunities to support long-term growth.

Vincent, age 7, has been receiving Clolar as part of a clinical trial and now has been in remission from leukemia for two years. He attends kindergarten in New York, where he and his parents are living during his treatment. Vincent looks forward to Fridays, when he sees his family in the Philippines via webcam.